Dept. of Physiology and Biophysics, Weill Medical College of Cornell Univ., 1300 York Ave., New York, NY 10065, USA.
Am J Physiol Renal Physiol. 2012 Jan 1;302(1):F20-6. doi: 10.1152/ajprenal.00480.2011. Epub 2011 Oct 19.
Epithelial Na+ channels (ENaC) can be regulated by both mineralocorticoid and glucocorticoid hormones. In the mammalian kidney, effects of mineralocorticoids have been extensively studied, but those of glucocorticoids are complicated by metabolism of the hormones and cross-occupancy of mineralocorticoid receptors. Here, we report effects of dexamethasone, a synthetic glucocorticoid, on ENaC in the rat kidney. Infusion of dexamethasone (24 μg/day) for 1 wk increased the abundance of αENaC 2.26 ± 0.04-fold. This was not accompanied by an induction of Na+ currents (I(Na)) measured in isolated split-open collecting ducts. In addition, hormone treatment did not increase the abundance of the cleaved forms of either αENaC or γENaC or the expression of βENaC or γENaC protein at the cell surface. The absence of hypokalemia also indicated the lack of ENaC activation in vivo. Dexamethasone increased the abundance of the Na+ transporters Na+/H+ exchanger 3 (NHE3; 1.36 ± 0.07-fold), Na(+)-K(+)-2Cl(-) cotransporter 2 (NKCC2; 1.49 ± 0.07-fold), and Na-Cl cotransporter (NCC; 1.72 ± 0.08-fold). Surface expression of NHE3 and NCC also increased with dexamethasone treatment. To examine whether glucocorticoids could either augment or inhibit the effects of mineralocorticoids, we infused dexamethasone (60 μg/day) together with aldosterone (12 μg/day). Dexamethasone further increased the abundance of αENaC in the presence of aldosterone, suggesting independent effects of the two hormones on this subunit. However, I(Na) was similar in animals treated with dexamethasone+aldosterone and with aldosterone alone. We conclude that dexamethasone can occupy glucocorticoid receptors in cortical collecting duct and induce the synthesis of αENaC. However, this induction is not sufficient to produce an increase in functional Na+ channels in the apical membrane, implying that the abundance of αENaC is not rate limiting for channel formation in the kidney.
上皮钠通道 (ENaC) 可受盐皮质激素和糖皮质激素的调节。在哺乳动物肾脏中,已对盐皮质激素的作用进行了广泛研究,但由于激素代谢和盐皮质激素受体的交叉占据,糖皮质激素的作用变得复杂。在这里,我们报告了合成糖皮质激素地塞米松对大鼠肾脏 ENaC 的影响。地塞米松(24μg/天)输注 1 周可使 αENaC 的丰度增加 2.26±0.04 倍。这并没有伴随着在分离的劈开收集管中测量的 Na+电流 (I(Na)) 的诱导。此外,激素处理并没有增加 αENaC 或 γENaC 的裂解形式的丰度,也没有增加细胞表面 βENaC 或 γENaC 蛋白的表达。低钾血症的缺乏也表明体内 ENaC 没有激活。地塞米松增加了 Na+/H+交换器 3 (NHE3; 1.36±0.07 倍)、Na(+)-K(+)-2Cl(-)共转运蛋白 2 (NKCC2; 1.49±0.07 倍) 和 Na-Cl 共转运蛋白 (NCC; 1.72±0.08 倍) 的丰度。NHE3 和 NCC 的表面表达也随地塞米松处理而增加。为了检查糖皮质激素是否可以增强或抑制盐皮质激素的作用,我们同时输注地塞米松(60μg/天)和醛固酮(12μg/天)。在醛固酮存在的情况下,地塞米松进一步增加了 αENaC 的丰度,表明这两种激素对该亚基有独立的作用。然而,用地塞米松+醛固酮处理的动物的 I(Na)与仅用醛固酮处理的动物相似。我们得出结论,地塞米松可以占据皮质集合管中的糖皮质激素受体并诱导 αENaC 的合成。然而,这种诱导不足以在顶端膜中产生功能性 Na+通道的增加,这意味着 αENaC 的丰度不是肾脏中通道形成的限速因素。